Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Crovalimab treatment in patients with paroxysmal nocturnal haemoglobinuria: Long‐term results from the phase I/II COMPOSER trial
Alexander Röth, Satoshi Ichikawa, Yoshikazu Ito, et al.
European Journal Of Haematology (2023) Vol. 111, Iss. 2, pp. 300-310
Open Access | Times Cited: 11

Showing 11 citing articles:

Phase 3 randomized COMMODORE 1 trial: Crovalimab versus eculizumab in complement inhibitor‐experienced patients with paroxysmal nocturnal hemoglobinuria
Phillip Scheinberg, Diego V. Clé, Jin Seok Kim, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 9, pp. 1757-1767
Closed Access | Times Cited: 13
Phase 3 randomized COMMODORE 2 trial: Crovalimab versus eculizumab in patients with paroxysmal nocturnal hemoglobinuria naive to complement inhibition
Alexander Röth, Guangsheng He, Hongyan Tong, et al.
American Journal of Hematology (2024) Vol. 99, Iss. 9, pp. 1768-1777
Open Access | Times Cited: 11
Crovalimab: First Approval
Sohita Dhillon
Drugs (2024) Vol. 84, Iss. 6, pp. 707-716
Closed Access | Times Cited: 8
Paroxysmal Nocturnal Hemoglobinuria: Current Management, Unmet Needs, and Recommendations
Monika Oliver, Christopher J. Patriquin
Journal of Blood Medicine (2023) Vol. Volume 14, pp. 613-628
Open Access | Times Cited: 12
Current status and perspectives of hematopoietic cell transplantation in patients with paroxysmal nocturnal hemoglobinuria
Marek Ussowicz, Dawid Przystupski, Patrycja Mensah‐Glanowska, et al.
Frontiers in Immunology (2025) Vol. 15
Open Access
Progress in clinical research on allogeneic hematopoietic stem cell transplantation for the treatment of paroxysmal nocturnal hemoglobinuria
Zhixue Li, Defu Zeng, Rong Fu, et al.
Medicine Plus (2025) Vol. 2, Iss. 1, pp. 100070-100070
Open Access
Pharmacokinetic characterization and exposure–response relationship of crovalimab in the COMMODORE 1, 2 and 3 and COMPOSER trials of patients with paroxysmal nocturnal haemoglobinuria
Valérie Cosson, Rong Fu, Austin Kulasekararaj, et al.
British Journal of Clinical Pharmacology (2025)
Open Access
Komplementinhibitoren in der Therapie der PNH: neue Substanzen - neue Optionen
Hubert Schrezenmeier, Sixten Körper, Astrid Marx-Hofmann
InFo Hämatologie + Onkologie (2024) Vol. 27, Iss. 4, pp. 20-24
Closed Access
Beyond Recycling Antibodies: Crovalimab’s Molecular Design Enables Four-Weekly Subcutaneous Injections for PNH Treatment
Zenjiro Sampei, Kenta Haraya, Siok Wan Gan, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 21, pp. 11679-11679
Open Access
Safety of Crovalimab Versus Eculizumab in Patients With Paroxysmal Nocturnal Haemoglobinuria (PNH): Pooled Results From the Phase 3 COMMODORE Studies
Alexander Röth, Rong Fu, Guangsheng He, et al.
European Journal Of Haematology (2024)
Open Access
Crovalimab in the paroxysmal nocturnal hemoglobinuria treatment landscape
Alexander Röth, Austin Kulasekararaj, Phillip Scheinberg, et al.
Immunotherapy (2024), pp. 1-12
Open Access
Page 1

Scroll to top